Analysis7 min2026-03-17

Where AI Delivers Real ROI in Pharma: Department-by-Department Breakdown

Every pharma company wants AI. Few know where to start.

The mistake most make: trying to deploy AI everywhere at once. The result is a portfolio of mediocre pilots that prove nothing. The smarter approach: identify the department where AI delivers the highest ROI with the lowest risk, prove it works, then expand.

Here's our ranking, based on analysis of pharma workflows across 50+ European companies.

Tier 1: Highest ROI, Lowest Risk

1. Medical Information — ROI Score: 9.2/10

  • 60–70% of queries are repetitive (high automation potential)
  • Response libraries already exist (structured knowledge base)
  • Clear success metrics (response time, accuracy, volume)
  • Low regulatory risk (non-promotional, well-defined boundaries)
  • 65% reduction in response preparation time
  • 3x increase in queries handled per FTE
  • 95%+ accuracy on standard queries
  • MSLs freed for 15+ additional HCP engagements per month

Investment: €990–€1,990/month | Payback: 6–8 weeks

2. Regulatory Affairs (Document Processing) — ROI Score: 8.7/10

  • Document cross-referencing is time-intensive and error-prone
  • Variation tracking across markets is highly structured
  • Submission preparation follows repeatable patterns
  • ROI is directly measurable (hours saved per submission)
  • 40% faster regulatory document preparation
  • 80% reduction in cross-referencing errors
  • Automated tracking of SmPC updates across 27 EU markets
  • €50K–€200K annual savings in outsourced regulatory work

Investment: €1,990–€4,990/month | Payback: 3–4 months

3. Pharmacovigilance (Case Processing) — ROI Score: 8.4/10

  • ICSR processing is highly structured (ideal for AI)
  • Volume is growing 20%+ annually (manual scaling is unsustainable)
  • Regulatory deadlines create urgency
  • Clear quality metrics (completeness, timeliness, accuracy)
  • 50% reduction in case processing time
  • 90% auto-classification accuracy for incoming reports
  • Zero missed regulatory deadlines
  • Reduction of PV outsourcing costs by 30–40%

Investment: €2,990–€5,990/month | Payback: 2–3 months

Tier 2: Good ROI, Medium Complexity

4. Commercial / Sales Operations — ROI Score: 7.5/10

  • HCP profiling and segmentation improves targeting
  • Content localization across markets is repetitive
  • CRM data enrichment increases rep productivity
  • Territory optimization uses pattern recognition
  • 25% improvement in HCP engagement rates
  • 50% reduction in content localization time
  • 15% increase in rep productivity (measured by meaningful interactions)

Challenge: Requires integration with CRM (Veeva, Salesforce), which adds complexity.

5. Clinical Operations — ROI Score: 7.1/10

  • Protocol feasibility assessment accelerates site selection
  • Patient recruitment optimization reduces enrollment timelines
  • Data monitoring flags issues earlier

Challenge: Clinical data is the most sensitive category. Implementation requires extensive validation and often dedicated IT security review. ROI is high but timeline is longer (3–6 months to production).

Tier 3: Wait Until You've Proven AI Elsewhere

6. R&D / Drug Discovery — ROI Score: 5.8/10

  • Extremely high complexity
  • Results take years to validate
  • Requires specialized ML expertise (not workflow automation)
  • Better served by dedicated biotech AI platforms (Insilico, Generate:Biomedicines)

7. Manufacturing / Supply Chain — ROI Score: 5.2/10

  • Requires IoT/sensor integration
  • Existing MES/ERP systems are deeply embedded
  • ROI is real but implementation is 12–18 months
  • Better to start after commercial/regulatory AI is proven

The Decision Framework

Ask these 3 questions to pick your starting department:

1. Volume of repetitive tasks? Higher repetition = higher AI ROI. MI and PV score highest.

2. Existing structured data? AI needs data to work. If the department already has organized response libraries, document templates, or case databases, it's ready.

3. Clear success metrics? If you can't measure it in week 3, you can't prove it to the board. MI and regulatory have the clearest metrics.

The Play

Start with MI or Regulatory. Run a 3-week pilot. Measure everything. Present the KPIs to leadership. Then use those results to fund expansion into PV, Commercial, and beyond.

This isn't theory — it's the pattern we see in every successful pharma AI deployment.

*kureus helps pharma teams identify their highest-ROI starting point and proves it in 3 weeks. Book your 20-minute diagnosis →*